CNBC's Leslie Picker joins 'Squawk Box ' to report on the company's quarterly earnings results.
Morgan Stanley Direct Lending offers a well-constructed portfolio of first-lien senior secured loans, with 95% geared towards non-cyclical industries, helping to ensure stability in a volatile market. MSDL's conservative management strategy, low non-accrual investments, and robust 132% dividend coverage make it an attractive choice for income-focused investors, yielding 9.5%. Trading near NAV, MSDL has potential for NAV/share accretion through retained capital, making it a compelling investment in a higher-for-longer interest rate environment.
Morgan Stanley's profit increased in the fourth quarter, fueled by a wave of dealmaking and stock sale by the investment bank.
Morgan Stanley's massive wealth management business will be helped by high stock market values in the fourth quarter. On Wednesday, JPMorgan Chase, Goldman Sachs and Citigroup each topped expectations, helped by better-than-expected revenue from trading or investment banking.
As Bank of America Corp BAC and Morgan Stanley MS prepare to report fourth-quarter earnings Thursday morning, Wall Street is watching. With both stocks riding high after a strong year, it's a showdown between Main Street lending and Wall Street dealmaking.
2024 was a tremendous year for Kinder Morgan (KMI 0.85%), with shares of the pipeline giant rebounding dramatically, gaining 55.3% in the year, according to data provided by S&P Global Market Intelligence. With those handsome gains, Kinder Morgan stock handily beat the S&P 500 (^GSPC 1.56%), which rallied around 23% in 2024.
Interest rate cuts that made it cheaper to borrow money, prompting more mergers and acquisitions in 2024.
As bond investors turn price setters, JP Morgan's James Sullivan expects bond vigilantes to hold significant sway on the incoming US administration's fiscal policy.
KMI's newest acquisition is a strategic addition to its midstream portfolio as it links natural gas supply from the Williston Basin region to high-demand markets.
Kinder Morgan 's (KMI 1.28%) main growth drivers in recent years have been its organic expansion projects. The natural gas pipeline giant has completed billions of dollars in projects and has more in the works.
On Wednesday, Vir Biotechnology, Inc. VIR presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a variety of HER2-expressing solid tumors, and VIR-5500, which targets PSMA in metastatic castration-resistant prostate cancer (mCRPC).
Executives acknowledge ‘not everyone will agree with this decision' as bank calls time on remote and hybrid working